Literature DB >> 19745722

Sex and cannabinoid CB1 genotype differentiate palatable food and cocaine self-administration behaviors in mice.

Sara Jane Ward1, Ellen A Walker.   

Abstract

Both cannabinoid CB1 receptor knockout and antagonism produce well-established attenuation of palatable food and drug self-administration behavior. Although cannabinoid drugs have received attention as pharmacotherapeutics for various disorders, including obesity and addiction, it is unclear whether these agents produce equivalent behavioral effects in females and males. In this study, acquisition of 32% corn oil or 10% Ensure self-administration, and maintenance of corn oil, Ensure, or 0.56 mg/kg/infusion cocaine self-administration under both fixed ratio (FR)-1 and progressive ratio (PR) schedule of reinforcement, was compared in male and female wild type (WT) and CB1 knockout (KO) mice. Furthermore, the effect of pretreatment with the CB1 antagonist SR141716 (0.3-3.0) on Ensure self-administration in male and female WT and CB1 KO mice was assessed. CB1 genotype and sex significantly interacted to produce an attenuation of acquisition and maintenance of Ensure self-administration and PR self-administration for both Ensure and cocaine in male CB1 KO mice. In contrast, male CB1 KO mice showed no deficit in acquisition and maintenance of FR-1 responding or in PR responding maintained by corn oil. Sex differences also arose within genotypes for responding maintained under all three reinforcers. Lastly, pretreatment with SR141716 attenuated Ensure self-administration in WT and CB1 KO mice but was approximately five-fold more potent in WT mice than in CB1 KOs. The present data add to a small but growing literature suggesting that the cannabinoid system may be differentially sensitive in its modulation of appetitive behavior in males versus females.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19745722      PMCID: PMC4568955          DOI: 10.1097/FBP.0b013e328331ba30

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  40 in total

1.  The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety.

Authors:  J Haller; N Bakos; M Szirmay; C Ledent; T F Freund
Journal:  Eur J Neurosci       Date:  2002-10       Impact factor: 3.386

2.  Lack of CB1 cannabinoid receptor impairs cocaine self-administration.

Authors:  Guadalupe Soria; Victoria Mendizábal; Clara Touriño; Patricia Robledo; Catherine Ledent; Marc Parmentier; Rafael Maldonado; Olga Valverde
Journal:  Neuropsychopharmacology       Date:  2005-09       Impact factor: 7.853

Review 3.  Endocannabinoids and drug dependence.

Authors:  Daniela Parolaro; Daniela Viganò; Tiziana Rubino
Journal:  Curr Drug Targets CNS Neurol Disord       Date:  2005-12

4.  Effects of a Cannabinoid1 receptor antagonist and Serotonin2C receptor agonist alone and in combination on motivation for palatable food: a dose-addition analysis study in mice.

Authors:  Sara Jane Ward; Timothy W Lefever; Cavario Jackson; Ronald J Tallarida; Ellen A Walker
Journal:  J Pharmacol Exp Ther       Date:  2008-02-06       Impact factor: 4.030

Review 5.  Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy.

Authors:  N R Richardson; D C Roberts
Journal:  J Neurosci Methods       Date:  1996-05       Impact factor: 2.390

6.  The estrous cycle affects cocaine self-administration on a progressive ratio schedule in rats.

Authors:  D C Roberts; S A Bennett; G J Vickers
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

7.  Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study.

Authors:  Luc F Van Gaal; Aila M Rissanen; André J Scheen; Olivier Ziegler; Stephan Rössner
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

8.  Reduced sensitivity to reward in CB1 knockout mice.

Authors:  Carles Sanchis-Segura; Brandon H Cline; Giovanni Marsicano; Beat Lutz; Rainer Spanagel
Journal:  Psychopharmacology (Berl)       Date:  2004-04-09       Impact factor: 4.530

9.  Sex differences in the cannabinoid modulation of appetite, body temperature and neurotransmission at POMC synapses.

Authors:  Shanna Diaz; Borzoo Farhang; Joshua Hoien; Megan Stahlman; Nadira Adatia; Jeremy M Cox; Edward J Wagner
Journal:  Neuroendocrinology       Date:  2009-01-09       Impact factor: 4.914

10.  Gene expression of opioid and dopamine systems in mouse striatum: effects of CB1 receptors, age and sex.

Authors:  Tonya M Gerald; Allyn C Howlett; Gregg R Ward; Cheryl Ho; Steven O Franklin
Journal:  Psychopharmacology (Berl)       Date:  2008-04-27       Impact factor: 4.530

View more
  12 in total

1.  State-dependent interactions between excitatory neuromodulators in the neuronal control of breathing.

Authors:  Atsushi Doi; Jan-Marino Ramirez
Journal:  J Neurosci       Date:  2010-06-16       Impact factor: 6.167

2.  Therapeutic potential of PIMSR, a novel CB1 receptor neutral antagonist, for cocaine use disorder: evidence from preclinical research.

Authors:  Ewa Galaj; Briana Hempel; Allamar Moore; Benjamin Klein; Guo-Hua Bi; Eliot L Gardner; Herbert H Seltzman; Zheng-Xiong Xi
Journal:  Transl Psychiatry       Date:  2022-07-18       Impact factor: 7.989

Review 3.  How to study sex differences in addiction using animal models.

Authors:  Marilyn E Carroll; Wendy J Lynch
Journal:  Addict Biol       Date:  2016-06-26       Impact factor: 4.280

4.  Cocaine self-administration in dopamine D₃ receptor knockout mice.

Authors:  S Barak Caine; Morgane Thomsen; Andrew C Barrett; Gregory T Collins; Peter Grundt; Amy Hauck Newman; Paul Butler; Ming Xu
Journal:  Exp Clin Psychopharmacol       Date:  2012-08-06       Impact factor: 3.157

5.  Sex-Specific Role for Egr3 in Nucleus Accumbens D2-Medium Spiny Neurons Following Long-Term Abstinence From Cocaine Self-administration.

Authors:  Michel Engeln; Swarup Mitra; Ramesh Chandra; Utsav Gyawali; Megan E Fox; David M Dietz; Mary Kay Lobo
Journal:  Biol Psychiatry       Date:  2019-11-01       Impact factor: 13.382

6.  Cannabinoid type 1 receptors in A2a neurons contribute to cocaine-environment association.

Authors:  Brandon D Turner; Nicholas K Smith; Kevin M Manz; Betty T Chang; Eric Delpire; Carrie A Grueter; Brad A Grueter
Journal:  Psychopharmacology (Berl)       Date:  2021-01-16       Impact factor: 4.530

7.  Decreased reward sensitivity in rats from the Fischer344 strain compared to Wistar rats is paralleled by differences in endocannabinoid signaling.

Authors:  Theresa Brand; Rainer Spanagel; Miriam Schneider
Journal:  PLoS One       Date:  2012-02-08       Impact factor: 3.240

8.  Behavioral effects of the cannabinoid CB1 receptor allosteric modulator ORG27569 in rats.

Authors:  Yuanyuan Ding; Yanyan Qiu; Li Jing; David A Thorn; Yanan Zhang; Jun-Xu Li
Journal:  Pharmacol Res Perspect       Date:  2014-08-24

9.  Housing conditions during self-administration determine motivation for cocaine in mice following chronic social defeat stress.

Authors:  Michel Engeln; Megan E Fox; Mary Kay Lobo
Journal:  Psychopharmacology (Berl)       Date:  2020-09-10       Impact factor: 4.530

Review 10.  Can We Selectively Reduce Appetite for Energy-Dense Foods? An Overview of Pharmacological Strategies for Modification of Food Preference Behavior.

Authors:  Ewa Bojanowska; Joanna Ciosek
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.